Insider Transactions in Q4 2023 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-6.18%
|
$400,000
$40.39 P/Share
|
|
Dec 13
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.82%
|
$120,000
$12.07 P/Share
|
|
Dec 12
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-3.1%
|
$400,000
$40.03 P/Share
|
|
Dec 12
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.97%
|
$120,000
$12.94 P/Share
|
|
Nov 15
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-6.18%
|
$390,000
$39.79 P/Share
|
|
Nov 15
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.82%
|
$130,000
$13.81 P/Share
|
|
Nov 14
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-3.14%
|
$390,000
$39.08 P/Share
|
|
Nov 14
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.01%
|
$150,000
$15.3 P/Share
|
|
Oct 17
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-6.18%
|
$360,000
$36.52 P/Share
|
|
Oct 17
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.82%
|
$190,000
$19.98 P/Share
|